Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7276 USD | -2.01% | -5.51% | +1.48% |
May. 14 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on VolitionRx Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering VolitionRx Limited
Cantor Fitzgerald | |
Benchmark Company | |
EF Hutton | |
Maxim | |
Aegis Capital |
EPS Revisions
- Stock Market
- Equities
- VNRX Stock
- Consensus VolitionRx Limited